Velavigo Bio Inc
Clinical trials sponsored by Velavigo Bio Inc, explained in plain language.
-
New drug VBC103 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called VBC103 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 255 participants will take part in this early-p…
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated May 03, 2026 19:32 UTC
-
New drug VBC101 targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called VBC101 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to attach to two cancer-related targets (EGFR and cMET) to deliver a toxic payload directly to cancer cells. The trial has two parts…
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated May 01, 2026 15:58 UTC